肝脏IL22RA1缺陷通过调节肝脏氧固醇促进肝脂肪变性
研究显示,肝脏IL22RA1在NAFLD小鼠和患者肝组织中下调,肝细胞特异性Il22ra1敲除小鼠出现饮食诱导的肝脂肪变性、胰岛素抵抗和炎症纤维化,机制涉及ATF3/氧固醇7α-羟化酶轴介导的3β-HCA积累,IL-22治疗可减轻该效应。
要点
- 肝细胞特异性Il22ra1敲除小鼠较flox/flox小鼠出现饮食诱导的肝脂肪变性、胰岛素抵抗和炎症纤维化。
- 肝脏IL22RA1缺陷通过ATF3/氧固醇7α-羟化酶轴促进3β-HCA沉积,进而激活LXRα促进脂肪生成。
- 恢复氧固醇7α-羟化酶或沉默肝脏ATF3可降低Il22ra1敲除小鼠肝脏3β-HCA和脂质含量。
核心结论
- IL22RA1以ATF3/氧固醇7α-羟化酶依赖方式在维持肝脏脂质稳态中起关键作用,并建立3β-HCA与肝脏脂质稳态之间的联系。
研究设计与样本
- 研究检测了棕榈酸处理的小鼠原代肝细胞、NAFLD模型小鼠及患者肝脏中IL22RA1的表达,并比较肝细胞特异性Il22ra1敲除小鼠与flox/flox小鼠的表型。
主要发现
- IL22RA1在棕榈酸处理的小鼠原代肝细胞、NAFLD模型小鼠肝脏及NAFLD患者肝脏中下调。
- 肝细胞特异性Il22ra1敲除小鼠较flox/flox小鼠出现饮食诱导的肝脂肪变性、胰岛素抵抗、糖耐量受损、炎症增加和纤维化。
- 肝脏IL22RA1缺陷通过ATF3/氧固醇7α-羟化酶轴促进3β-HCA沉积,3β-HCA通过激活LXRα促进小鼠原代肝细胞和人肝类器官脂肪生成,IL-22处理可减弱该效应。
- 恢复氧固醇7α-羟化酶或沉默肝脏ATF3可降低肝细胞特异性Il22ra1敲除小鼠肝脏3β-HCA和脂质含量。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: An imbalance in lipid metabolism is the main cause of NAFLD. While the pathogenesis of lipid accumulation mediated by extrahepatic regulators has been extensively studied, the intrahepatic regulators modulating lipid homeostasis remain unclear. Previous studies have shown that systemic administration of IL-22 protects against NAFLD; however, the role of IL-22/IL22RA1 signaling in modulating hepatic lipid metabolism remains uncertain. APPROACH AND RESULTS: This study shows that hepatic IL22RA1 is vital in hepatic lipid regulation. IL22RA1 is downregulated in palmitic acid-treated mouse primary hepatocytes, as well as in the livers of NAFLD model mice and patients. Hepatocyte-specific Il22ra1 knockout mice display diet-induced hepatic steatosis, insulin resistance, impaired glucose tolerance, increased inflammation, and fibrosis compared with flox/flox mice. This is attributed to increased lipogenesis mediated by the accumulation of hepatic oxysterols, particularly 3 beta-hydroxy-5-cholestenoic acid (3β HCA). Mechanistically, hepatic IL22RA1 deficiency facilitates 3β HCA deposition through the activating transcription factor 3/oxysterol 7 alpha-hydroxylase axis. Notably, 3β HCA facilitates lipogenesis in mouse primary hepatocytes and human liver organoids by activating liver X receptor-alpha signaling, but IL-22 treatment attenuates this effect. Additionally, restoring oxysterol 7 alpha-hydroxylase or silencing hepatic activating transcription factor 3 reduces both hepatic 3β HCA and lipid contents in hepatocyte-specific Il22ra1 knockout mice. CONCLUSIONS: These findings indicate that IL22RA1 plays a crucial role in maintaining hepatic lipid homeostasis in an activating transcription factor 3/oxysterol 7 alpha-hydroxylase-dependent manner and establish a link between 3β HCA and hepatic lipid homeostasis.
引用
- Huang Y, Yu F, Ding Y, et al. Hepatic IL22RA1 deficiency promotes hepatic steatosis by modulating oxysterol in the liver. Hepatology. 2024. PMID: 38985984. doi:10.1097/HEP.0000000000000998
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。